DarioHealth Corp. reported its financial results for the first quarter of 2026, revealing total revenues of $5.584 million, a decrease of 17.3% from $6.752 million in the same period of 2025. The decline was primarily attributed to a drop in service revenues, which fell to $2.826 million from $4.875 million year-over-year. In contrast, consumer hardware revenues increased to $2.758 million, up from $1.877 million, indicating a shift in revenue sources. The company recorded a net loss of $8.249 million for the quarter, compared to a net loss of $9.227 million in the prior year, reflecting a slight improvement in profitability.
The company’s operational metrics showed a significant change in customer engagement, with revenues from Business-to-Business-to-Consumer (B2B2C) arrangements totaling $2.716 million, down from $4.737 million in the previous year. Consumer revenues also saw a slight increase, rising to $2.868 million from $2.015 million. DarioHealth's total assets decreased to $103.281 million as of March 31, 2026, down from $110.075 million at the end of 2025, largely due to a reduction in cash and cash equivalents, which fell to $14.977 million from $21.803 million.
Strategically, DarioHealth completed the acquisition of Twill in February 2024, enhancing its digital therapeutic offerings. Twill's Intelligent Healing Platform integrates artificial intelligence with personalized care solutions, which the company aims to leverage for expanding its market presence. The company also reported an increase in its employee headcount, reflecting ongoing investments in its operational capabilities and product development.
Despite the challenges, DarioHealth remains focused on its long-term growth strategy, which includes enhancing product adoption rates and expanding its geographic reach. The company noted that it expects to continue incurring losses as it invests in the development and commercialization of its products. Management indicated that future operations will be funded through existing cash reserves and potential financing transactions, although there is substantial doubt about the company's ability to continue as a going concern over the next twelve months.
Looking ahead, DarioHealth's management emphasized the importance of achieving profitability through successful product launches and market penetration. The company is actively working to strengthen its relationships with key partners and enhance its service offerings to improve customer engagement and retention. However, the ongoing geopolitical tensions in the Middle East and their potential impact on market conditions remain a concern for the company’s future operations.
About DarioHealth Corp.
DarioHealth is a global digital health company specializing in whole-person health management. It offers personalized digital therapeutics and virtual care solutions across physical, mental, and behavioral health conditions. Serving employers, health plans, pharmaceutical companies, and consumers, it leverages AI, data analytics, and engaging user experiences to deliver improved clinical outcomes, cost savings, and high ROI through integrated, scalable platforms focused on chronic disease, mental health, and preventive care.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.